Home › Macular Degeneration › Georgia
Macular Degeneration clinical trials in Georgia
6 studies for Macular Degeneration are looking for participants at sites in Georgia.
Cities in Georgia
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Georgia Retina, Marietta
- Marietta Eye Clinic, Marietta
RecruitingPhase 2/3
Ages 60 and older · All sexes · Updated Sep 30, 2026 · NCT06635148A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Southeast Retina Center, Augusta
- Georgia Retina - Marietta, Marietta
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 18, 2026 · NCT06541704A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- Emory University Eye Center, Atlanta
RecruitingPhase 1
Ages 50 and older · All sexes · Updated Sep 3, 2026 · NCT03178149Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Thomas Eye Group, Sandy Springs
RecruitingPhase 3
Ages 50 and older · All sexes · Updated Apr 16, 2026 · NCT07064759Active AMD Study to Improve Function in Veterans
- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur
Recruiting
Ages 65 to 89 · All sexes · Updated Feb 23, 2026 · NCT05932069Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration
- CBCC Global Research Site:001, Augusta
RecruitingPhase 1
Ages 50 and older · All sexes · Updated Feb 7, 2025 · NCT06132035From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.